Treatment with insulin and several other insulin secretagogues can cause hypoglycemia, which remains a major limiting factor in achieving euglycemia in patients with type 1 diabetes (T1D) or T2D (3, 4, 54). The gene discussed is INS; the disease is type 2 diabetes mellitus.